Publication | Closed Access

Effects of tolcapone, a catechol-O-methyltransferase inhibitor, on motor symptoms and pharmacokinetics of levodopa in patients with Parkinson's disease

MedicineParkinson DiseaseNeuropharmacologyCatechol-o-methyltransferase InhibitorNeurologyPharmacologyMotor SymptomsMovement Disorders